Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014)

Vertex Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $14.2 million for Q4 2014.

• In Q4 2014, Current Taxes changed N/A year-over-year to $14.2 million; the TTM figure through Dec 2014 stood at $14.2 million (changed N/A YoY), while the FY2014 annual figure was $14.2 million, changed N/A from the prior year.
• Current Taxes for Q4 2014 stood at $14.2 million, up from $715000.0 in the prior quarter.
• The five-year high for Current Taxes was $14.2 million in Q4 2014, with the low at $201000.0 in Q1 2012.
• The 3-year median for Current Taxes is $3.9 million (2012), against an average of $5.9 million.
• Peak annual rise in Current Taxes reached 60.32% in 2012, while the deepest fall reached 94.08% in 2012.
• Vertex Pharmaceuticals' Current Taxes stood at $12.1 million in 2011, then tumbled by 94.08% to $715000.0 in 2012, then soared by 1886.85% to $14.2 million in 2014.
• Business Quant data shows VRTX's Current Taxes at $14.2 million in Q4 2014, $715000.0 in Q4 2012, and $3.9 million in Q3 2012.